Terms: = Prostate cancer AND PAX7, PAX7B, 5081, ENSG00000009709, P23759, HUP1
6 results:
1. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results.
Amparore D; De Cillis S; Schulman C; Kadner G; Fiori C; Porpiglia F
Minerva Urol Nephrol; 2023 Dec; 75(6):743-751. PubMed ID: 37350585
[TBL] [Abstract] [Full Text] [Related]
2. How accurate is
Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
[TBL] [Abstract] [Full Text] [Related]
3. An autopsy case of prostatic rhabdomyosarcoma with DICER1 hotspot mutation.
Miyama Y; Makise N; Miyakawa J; Kume H; Fukayama M; Ushiku T
Pathol Int; 2021 Jan; 71(1):102-108. PubMed ID: 33112496
[TBL] [Abstract] [Full Text] [Related]
4. Disturbed colonic motility contributes to anorectal symptoms and dysfunction after radiotherapy for carcinoma of the prostate.
Yeoh EK; Bartholomeusz DL; Holloway RH; Fraser RJ; Botten R; Di Matteo A; Moore JW; Schoeman MN
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):773-80. PubMed ID: 20153122
[TBL] [Abstract] [Full Text] [Related]
5. Biochemical outcome for hormone-naïve patients with high-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external-beam radiation.
Merrick GS; Butler WM; Lief JH; Galbreath RW; Adamovich E
Cancer J; 2002; 8(4):322-7. PubMed ID: 12184410
[TBL] [Abstract] [Full Text] [Related]
6. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study.
Bridge JA; Liu J; Weibolt V; Baker KS; Perry D; Kruger R; Qualman S; Barr F; Sorensen P; Triche T; Suijkerbuijk R
Genes Chromosomes Cancer; 2000 Apr; 27(4):337-44. PubMed ID: 10719362
[TBL] [Abstract] [Full Text] [Related]
